Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19

Abstract Background There is no proven antiviral or immunomodulatory therapy for coronavirus disease 2019 (COVID-19). The disease progression associated with the proinflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to severe COVID-19...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 71; no. 16; pp. 2114 - 2120
Main Authors Fadel, Raef, Morrison, Austin R, Vahia, Amit, Smith, Zachary R, Chaudhry, Zohra, Bhargava, Pallavi, Miller, Joseph, Kenney, Rachel M, Alangaden, George, Ramesh, Mayur S
Format Journal Article
LanguageEnglish
Published US Oxford University Press 19.11.2020
Subjects
Online AccessGet full text

Cover

Loading…